Test accuracy of interferon-γ release assays (IGRAs) for diagnosing TB differs when using
older or precommercial tools and inconsistent diagnostic criteria. This metaanalysis critically …

Objective: To determine whether interferon-gamma release assays (IGRAs) improve the
identification of HIV-infected individuals who could benefit from latent tuberculosis infection …

In 2005, CDC published guidelines for using the QuantiFERON-TB Gold test (QFT-
G)(Cellestis Limited, Carnegie, Victoria, Australia)(CDC. Guidelines for using the …

This report updates and combines earlier versions of guidelines for the prevention and
treatment of opportunistic infections (OIs) in HIV-infected adults (ie, persons aged> 18 years) …

Background: Until recently, the tuberculin skin test was the only test for detecting latent
tuberculosis (TB) infection, but 2 ex vivo interferon-γ release assays (IGRAs) are now …

Rationale: In the absence of active tuberculosis, a positive tuberculin skin test (TST) or
interferon-γ release assay (IGRA) result defines latent infection with Mycobacterium …

The century-old tuberculin skin test (TST) was until recently the only means of diagnosing
latent tuberculosis infection (LTBI). Recent advances in mycobacterial genomics and human …

Tuberculosis (TB) and diabetes mellitus (DM) are both important health issues. A
bidirectional association between them has been demonstrated by many researchers. The …

Targeted testing and treatment of individuals with latent tuberculosis infection at increased
risk of progression to active disease is a key element of tuberculosis control. This strategy is …

Background Despite the widespread use of interferon-γ release assays (IGRAs), their role in
diagnosing tuberculosis and targeting preventive therapy in HIV-infected patients remains …